North America Intravenous Immunoglobulin Market : Table of Contents

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Intravenous Immunoglobulin Market, by Geography

2.2 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Intravenous Immunoglobulin Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Global PEST Analysis

5. Intravenous Immunoglobulin Market - Key Industry Dynamics

5.1 Market Drivers:

5.1.1 Increase in Use of Immunoglobulins

5.1.2 Rising Immunodeficiency Disease Prevalence

5.2 Market Restraints

5.2.1 High Cost of Therapy

5.3 Market Opportunities

5.3.1 New Product Launches and Approvals

5.4 Future Trends

5.4.1 Strong Pipeline of IVIG Candidates

5.5 Impact Analysis:

6. Intravenous Immunoglobulin Market – North America Market Analysis

6.1 Intravenous Immunoglobulin Market Revenue (US$ Mn), 2022 – 2030

7. North America Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 – by Type

7.1 Overview

7.2 Intravenous Immunoglobulin Market Revenue Share, by Type, 2022 & 2030 (%)

7.3 IgG

7.3.1 Overview

7.3.2 IgG: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

7.4 IgA

7.4.1 Overview

7.4.2 IgA: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

7.5 IgM

7.5.1 Overview

7.5.2 IgM: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8. North America Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 – by Application

8.1 Overview

8.2 Intravenous Immunoglobulin Market Revenue Share, by Application, 2022 & 2030 (%)

8.3 Immunodeficiency Diseases

8.3.1 Overview

8.3.2 Immunodeficiency Diseases: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Chronic Inflammatory Demyelinating Polyneuropathy

8.4.1 Overview

8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Idiopathic Thrombocytopenic Purpura

8.5.1 Overview

8.5.2 Idiopathic Thrombocytopenic Purpura: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.6 Multifocal Motor Neuropathy

8.6.1 Overview

8.6.2 Multifocal Motor Neuropathy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.7 Hypogammaglobulinemia

8.7.1 Overview

8.7.2 Hypogammaglobulinemia: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.8 Guillain-Barre Syndrome

8.8.1 Overview

8.8.2 Guillain-Barre Syndrome: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.9 Specific Antibody Deficiency

8.9.1 Overview

8.9.2 Specific Antibody Deficiency: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.10 Inflammatory Myopathies

8.10.1 Overview

8.10.2 Inflammatory Myopathies: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.11 Myasthenia Gravis

8.11.1 Overview

8.11.2 Myasthenia Gravis: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

8.12 Others

8.12.1 Overview

8.12.2 Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 – by Distribution Channel

9.1 Overview

9.2 Intravenous Immunoglobulin Market Revenue Share, by Route of Administration, 2022 & 2030 (%)

9.3 Hospital Pharmacy

9.3.1 Overview

9.3.2 Hospital Pharmacy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Retail Pharmacy

9.4.1 Overview

9.4.2 Retail Pharmacy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 – by End User

10.1 Overview

10.2 Intravenous Immunoglobulin Market Revenue Share, by Species, 2022 & 2030 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

10.4 Specialty Clinics

10.4.1 Overview

10.4.2 Specialty Clinics: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

11. North America Intravenous Immunoglobulin Market - Geographical Analysis

11.1 North America Intravenous Immunoglobulin Market, Revenue and Forecast To 2030

11.1.1 Overview

11.1.2 North America Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

11.1.3 North America: Intravenous Immunoglobulin Market, by Type, 2020–2030 (US$ Million)

11.1.4 North America: Intravenous Immunoglobulin Market, by Application, 2020–2030 (US$ Million)

11.1.5 North America: Intravenous Immunoglobulin Market, by Distribution Channel, 2020–2030 (US$ Million)

11.1.6 North America: Intravenous Immunoglobulin Market, by End User, 2020–2030 (US$ Million)

11.1.7 North America Intravenous Immunoglobulin Market, by Country

11.1.7.1 US

11.1.7.1.1 Overview

11.1.7.1.2 US Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

11.1.7.1.3 US: Intravenous Immunoglobulin Market, by Type, 2020–2030 (US$ Million)

11.1.7.1.4 US: Intravenous Immunoglobulin Market, by Application, 2020–2030 (US$ Million)

11.1.7.1.5 US: Intravenous Immunoglobulin Market, by Distribution Channel, 2020–2030 (US$ Million)

11.1.7.1.6 US: Intravenous Immunoglobulin Market, by End User, 2020–2030 (US$ Million)

11.1.7.2 Canada

11.1.7.2.1 Overview

11.1.7.2.2 Canada Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

11.1.7.2.3 Canada: Intravenous Immunoglobulin Market, by Type, 2020–2030 (US$ Million)

11.1.7.2.4 Canada: Intravenous Immunoglobulin Market, by Application, 2020–2030 (US$ Million)

11.1.7.2.5 Canada: Intravenous Immunoglobulin Market, by Distribution Channel, 2020–2030 (US$ Million)

11.1.7.2.6 Canada: Intravenous Immunoglobulin Market, by End User, 2020–2030 (US$ Million)

11.1.7.3 Mexico

11.1.7.3.1 Overview

11.1.7.3.2 Mexico Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

11.1.7.3.3 Mexico: Intravenous Immunoglobulin Market, by Type, 2020–2030 (US$ Million)

11.1.7.3.4 Mexico: Intravenous Immunoglobulin Market, by Application, 2020–2030 (US$ Million)

11.1.7.3.5 Mexico: Intravenous Immunoglobulin Market, by Distribution Channel, 2020–2030 (US$ Million)

11.1.7.3.6 Mexico: Intravenous Immunoglobulin Market, by End User, 2020–2030 (US$ Million)

12. North America Intravenous Immunoglobulin Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in North America Intravenous Immunoglobulin Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Takeda Pharmaceutical Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Grifols SA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 ADMA Biologics, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bio Products Laboratory Ltd.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Octapharma AG

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Kedrion SpA

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 CSL Ltd

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 LFB Group

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Prothya Biosolutions B.V.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. North America Intravenous Immunoglobulin Market Segmentation

Table 2. North America Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 3. North America Intravenous Immunoglobulin Market, by Application– Revenue and Forecast to 2030 (US$ Million)

Table 4. North America Intravenous Immunoglobulin Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)

Table 5. North America Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2030 (US$ Million)

Table 6. US Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 7. US Intravenous Immunoglobulin Market, by Application– Revenue and Forecast to 2030 (US$ Million)

Table 8. US Intravenous Immunoglobulin Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)

Table 9. US Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2030 (US$ Million)

Table 10. Canada Intravenous Immunoglobulin Market, by Type– Revenue and Forecast to 2030 (US$ Million)

Table 11. Canada Intravenous Immunoglobulin Market, by Application– Revenue and Forecast to 2030 (US$ Million)

Table 12. Canada Intravenous Immunoglobulin Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)

Table 13. Canada Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2030 (US$ Million)

Table 14. Mexico Intravenous Immunoglobulin Market, by Type– Revenue and Forecast to 2030 (US$ Million)

Table 15. Mexico Intravenous Immunoglobulin Market, by Application– Revenue and Forecast to 2030 (US$ Million)

Table 16. Mexico Intravenous Immunoglobulin Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)

Table 17. Mexico Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2030 (US$ Million)

Table 18. Recent Inorganic Growth Strategies in the North America Intravenous Immunoglobulin Market

Table 19. Recent Organic Growth Strategies in North America Intravenous Immunoglobulin Market

Table 20. Glossary of Terms, North America Intravenous Immunoglobulin Market

List of Figures

Figure 1. Intravenous Immunoglobulin Market Segmentation, By Geography

Figure 2. Global - PEST Analysis

Figure 3. Intravenous Immunoglobulin Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Intravenous Immunoglobulin Market Revenue (US$ Mn), 2022 – 2030

Figure 6. Intravenous Immunoglobulin Market Revenue Share, by Type, 2022 & 2030 (%)

Figure 7. IgG: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8. IgA: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. IgM: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11. Intravenous Immunoglobulin Market Revenue Share, by Application, 2022 & 2030 (%)

Figure 12. Immunodeficiency Diseases: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Chronic Inflammatory Demyelinating Polyneuropathy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14. Idiopathic Thrombocytopenic Purpura: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. Multifocal Motor Neuropathy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. Hypogammaglobulinemia: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17. Guillain-Barre Syndrome: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18. Specific Antibody Deficiency: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19. Inflammatory Myopathies: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20. Myasthenia Gravis: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21. Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22. Intravenous Immunoglobulin Market Revenue Share, by Route of Administration, 2022 & 2030 (%)

Figure 23. Hospital Pharmacy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24. Retail Pharmacy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25. Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26. Intravenous Immunoglobulin Market Revenue Share, Species, 2022 & 2030 (%)

Figure 27. Hospitals: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28. Specialty Clinics: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29. Others: Intravenous Immunoglobulin Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30. North America: Intravenous Immunoglobulin Market, by Key Country – Revenue (2022) (US$ Million)

Figure 31. North America Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. North America Intravenous Immunoglobulin Market, By Key Countries, 2022 and 2030 (%)

Figure 33. US Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

Figure 34. Canada Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

Figure 35. Mexico Intravenous Immunoglobulin Market Revenue and Forecast to 2030 (US$ Mn)

Figure 36. Growth Strategies in North America Intravenous Immunoglobulin Market